Clinical Research Progress of BTK Inhibitors in the Treatment of Autoimmune Diseases
This article briefly summarizes the role of BTK in the BCR signaling pathway, the development process of BTK inhibitors, and especially the latest progress of their clinical trials for the treatment of AD.PMID:37861005 | DOI:10.2174/0115680266264515230921052521
Source: Current Topics in Medicinal Chemistry - Category: Chemistry Authors: Pei Lin Dandan Zhang Jun Lin Source Type: research
More News: Arthritis | Autoimmune Disease | Chemistry | Clinical Trials | Lupus | Multiple Sclerosis | Rheumatoid Arthritis | Rheumatology